. | High GADA titer autoimmune diabetes (n = 123) . | . | Low GADA titer autoimmune diabetes (n = 127) . | . | ||
---|---|---|---|---|---|---|
. | High and moderate HLA risk* . | Low HLA risk† . | High and moderate HLA risk* . | Low HLA risk† . | ||
n | 42 | 81 | 35 | 92 | ||
Genotypes | ||||||
C1858C | 33 (78.6) | 65 (80.2) | 33 (94.3) | 87 (94.6) | ||
C1858T | 8 (19) | 16 (19.8) | 2 (5.7) | 5 (5.4) | ||
T1858T | 1 (2.4) | 0 (0) | 0 (0) | 0 (0) | ||
Alleles | ||||||
C | 74 (88.1) | 146 (90.1) | 68 (97.1) | 179 (97.3) | ||
T | 10 (11.9) | 16 (9.9) | 2 (2.9) | 5 (2.7) | ||
Phenotypes | ||||||
CT/TT genotypes | 9 (21.4) | 16 (19.8) | 2 (5.7) | 5 (5.4) | ||
CC genotype | 33 (78.6) | 65 (80.2) | 33 (94.3) | 87 (94.6) |
. | High GADA titer autoimmune diabetes (n = 123) . | . | Low GADA titer autoimmune diabetes (n = 127) . | . | ||
---|---|---|---|---|---|---|
. | High and moderate HLA risk* . | Low HLA risk† . | High and moderate HLA risk* . | Low HLA risk† . | ||
n | 42 | 81 | 35 | 92 | ||
Genotypes | ||||||
C1858C | 33 (78.6) | 65 (80.2) | 33 (94.3) | 87 (94.6) | ||
C1858T | 8 (19) | 16 (19.8) | 2 (5.7) | 5 (5.4) | ||
T1858T | 1 (2.4) | 0 (0) | 0 (0) | 0 (0) | ||
Alleles | ||||||
C | 74 (88.1) | 146 (90.1) | 68 (97.1) | 179 (97.3) | ||
T | 10 (11.9) | 16 (9.9) | 2 (2.9) | 5 (2.7) | ||
Phenotypes | ||||||
CT/TT genotypes | 9 (21.4) | 16 (19.8) | 2 (5.7) | 5 (5.4) | ||
CC genotype | 33 (78.6) | 65 (80.2) | 33 (94.3) | 87 (94.6) |
Data are n (%).
High-risk genotypes: DRB1*03-DQB1*0201/DRB1*04-DQB1*0302 genotype (DRB1*04 different from 0403); moderate-risk genotypes: DRB1*04-DQB1*0302/DRB1*04-DQB1*0302, DRB1*03-DQB1*0201/DRB1*03-DQB1*0201, DRB1*04-DQB1*0302/X, and DRB1*03/X (X different from DRB1*03, DRB1*0403-DQB1*0302, or DQB1*0602/03) genotypes.
Low risk genotypes: all the other genotypes.